Uveal Melanoma — Trials

Uveal Melanoma — Trials · CancerIndex

Clinical trials

Registered studies

232 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 59
Recruiting: 29
Ph III recruiting: 6
Growth YoY: —
Industry share: 36%
Top sponsor: IDEAYA Biosciences
Termination share: 33.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (34)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05677373	Testing the Safety and Effectiveness of Combining Two Drugs, PLX2853 and Trametinib in the Treatment of Advanced Uveal Melanoma	withdrawn	Phase 1 / Phase 2	0	Alliance for Clinical Trials in OncologyOTHER	0	Aug 18, 2023	clinicaltrials
NCT03326258	Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by Surgery	withdrawn	Phase 1 / Phase 2	0	National Cancer Institute (NCI)NIH	0	Jul 18, 2018